Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CASIRIVIMAB\IMDEVIMAB vs CEFAZOLIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CASIRIVIMAB\IMDEVIMAB vs CEFAZOLIN: Safety Overview

Metric CASIRIVIMAB\IMDEVIMAB CEFAZOLIN
Total FAERS Reports 4,248 5,113
Deaths Reported 137 345
Death Rate 3.2% 6.7%
Hospitalizations 1,351 2,331
Average Patient Age 54.3 yrs 54.8 yrs
% Female Patients 55.4% 53.1%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer N/A A-S Medication Solutions
Route N/A INTRAMUSCULAR
Marketing Status N/A Discontinued